Ayala Pharmaceuticals, Inc.

CIK: 0001100397

SEC Filings for Ayala Pharmaceuticals, Inc.

DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Form Type: DEFA14A

Filing Date: 2014-05-20

View Filing

DEFR14A - Revised definitive proxy soliciting materials

Form Type: DEFR14A

Filing Date: 2014-05-20

View Filing

8-K - Current report

Form Type: 8-K

Filing Date: 2014-05-06

View Filing

8-K - Current report

Form Type: 8-K

Filing Date: 2014-04-30

View Filing

DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Form Type: DEFA14A

Filing Date: 2014-04-08

View Filing

8-K - Current report

Form Type: 8-K

Filing Date: 2014-04-01

View Filing

424B2 - Prospectus [Rule 424(b)(2)]

Form Type: 424B2

Filing Date: 2014-03-28

View Filing

424B5 - Prospectus [Rule 424(b)(5)]

Form Type: 424B5

Filing Date: 2014-03-26

View Filing

8-K - Current report

Form Type: 8-K

Filing Date: 2014-03-24

View Filing

8-K - Current report

Form Type: 8-K

Filing Date: 2014-03-24

View Filing